My concerns are the current BOD has no clue what is going on in the biotech world. Should they sell now? should they continue to develop at a less than snails pace due to lack of resources? are technolgies dying on the vine because SK has never done a deal and doesn't know how? will the BOD do a shady deal that sells shareholder's short and gives the mgmt team a big kicker after the damamge is done? No experience, no oversight and no accountability. To add insult is they are way overpaid and extremely overpaid given they bring nothing to the party other than being ES cronnies. What does ES bring to the party? Nothing but baggage as a penny stock operator. What about the 20,000 put options? Where did the player that did that get the balls (and info) to put that bet out there?
Can anyone point out anything positive about the BOD?
Frustrated, although I share your "frustration" I believe there are many mistatements in your response and it is too early on a Sunday morning to get into them all. I will choose one.
Your statement about the RS and $5 is so manipulative and incorrect. The purpose of the RS was to get us over a $1 and had nothing to do with $5. The price at the time of the split was .64 and at a 1:5 meant a split price of $3.20. That is the number. $5 has nothing to do with it. That said, the current pps of $1.36 is bad enough but you do not need a sledge hammer to pound in a small nail. Stick to the facts as there are many out there to beat up the company right now and you do not need to twist things to make them worse.
News 
Market Data 
Discover 
